AMNEAL PHARMACEUTICALS INC (AMRX)

US03168L1052 - Common Stock

5.87  -0.03 (-0.51%)

After market: 5.74 -0.13 (-2.21%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
2.39B2.21B2.09B1.99B1.63B
Minority Interest Expense
-35.27M124.80M-9.55M22.50M241.70M
Cost Of Goods
1.54B1.42B1.30B1.33B1.15B
Gross Profit
856.66M795.82M791.66M663.00M479.20M
Operating Expenses
581.82M596.52M575.27M517.20M491.90M
Research and Development
163.95M195.69M201.85M179.90M188.00M
Selling, General, and Administrative Expenses
433.50M404.06M373.22M337.40M303.80M
Operating Income
274.85M199.30M216.40M145.70M-12.70M
Interest Income/Expense
-208.96M-170.74M-136.68M-129.60M-173.20M
Other Income/Expense
-35.69M17.54M15.33M2.60M1.50M
Non Recurring Items
-70.47M-294.23M-63.68M-54.40M-35.80M
Income Before Taxes
-40.27M-248.13M31.37M-35.80M-220.20M
Income Tax
8.45M6.66M11.20M5.60M383.30M
Net Income
-83.99M-129.99M10.62M91.10M-361.90M
EBITDA
504.25M439.48M449.80M381.10M194.50M
 
Per Share Data
EPS Diluted Total Ops
-0.48-0.860.070.61-2.74
Non GAAP EPS
N/A0.680.840.630.35
 
Statistics
Gross Profit Margin
35.79%35.97%37.81%33.27%29.46%
Profit Margin
-3.51%-5.88%0.51%4.57%-22.25%
Operating Profit Margin
11.48%9.01%10.34%7.31%-0.78%

All data in USD

Charts